| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asparagine | 1 | 2021 | 44 | 0.770 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 2021 | 24 | 0.760 |
Why?
|
| Carcinoma, Pancreatic Ductal | 8 | 2021 | 1828 | 0.750 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2021 | 59 | 0.750 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2021 | 256 | 0.740 |
Why?
|
| Pancreatic Neoplasms | 7 | 2021 | 5257 | 0.620 |
Why?
|
| Lumican | 4 | 2018 | 25 | 0.570 |
Why?
|
| Auranofin | 2 | 2016 | 36 | 0.570 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 73 | 0.550 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.550 |
Why?
|
| Oncolytic Viruses | 1 | 2017 | 169 | 0.490 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2013 | 153 | 0.490 |
Why?
|
| Thioredoxin Reductase 1 | 2 | 2016 | 15 | 0.480 |
Why?
|
| Erlotinib Hydrochloride | 2 | 2015 | 398 | 0.480 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 3 | 2011 | 382 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 2069 | 0.350 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 2196 | 0.350 |
Why?
|
| ErbB Receptors | 2 | 2015 | 2375 | 0.340 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 2 | 2020 | 10 | 0.330 |
Why?
|
| Luciferases | 3 | 2013 | 460 | 0.330 |
Why?
|
| Genetic Therapy | 2 | 2017 | 1716 | 0.330 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2016 | 5574 | 0.320 |
Why?
|
| Lung Neoplasms | 8 | 2016 | 12033 | 0.310 |
Why?
|
| STAT3 Transcription Factor | 2 | 2012 | 1136 | 0.300 |
Why?
|
| Cell Line, Tumor | 13 | 2021 | 14849 | 0.290 |
Why?
|
| Cell Survival | 6 | 2019 | 3063 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 1281 | 0.290 |
Why?
|
| Pancreatic Stellate Cells | 2 | 2018 | 78 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 1903 | 0.280 |
Why?
|
| Autophagy | 3 | 2018 | 911 | 0.280 |
Why?
|
| Signal Transduction | 7 | 2020 | 12103 | 0.270 |
Why?
|
| Immediate-Early Proteins | 2 | 2004 | 105 | 0.270 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 258 | 0.270 |
Why?
|
| Mice | 20 | 2021 | 35600 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2021 | 3917 | 0.260 |
Why?
|
| Forkhead Transcription Factors | 2 | 2008 | 763 | 0.260 |
Why?
|
| Cell Proliferation | 6 | 2021 | 7238 | 0.260 |
Why?
|
| Transforming Growth Factor beta | 2 | 2016 | 1109 | 0.250 |
Why?
|
| Apoptosis | 8 | 2021 | 7757 | 0.240 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2021 | 4961 | 0.210 |
Why?
|
| Animals | 20 | 2021 | 61956 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2016 | 9042 | 0.200 |
Why?
|
| Mice, Inbred NOD | 2 | 2021 | 896 | 0.190 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 14617 | 0.190 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2021 | 44 | 0.190 |
Why?
|
| Up-Regulation | 1 | 2007 | 2422 | 0.180 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 659 | 0.180 |
Why?
|
| Nod Signaling Adaptor Proteins | 1 | 2020 | 2 | 0.180 |
Why?
|
| Mice, SCID | 2 | 2021 | 1826 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 885 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4821 | 0.170 |
Why?
|
| Genistein | 1 | 2019 | 74 | 0.170 |
Why?
|
| Glioma | 2 | 2008 | 1978 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 3216 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 1563 | 0.160 |
Why?
|
| Matrix Attachment Region Binding Proteins | 2 | 2009 | 25 | 0.150 |
Why?
|
| Aminopyridines | 1 | 2020 | 223 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2011 | 2887 | 0.150 |
Why?
|
| Tumor Burden | 2 | 2021 | 2033 | 0.140 |
Why?
|
| Introns | 2 | 2009 | 461 | 0.140 |
Why?
|
| Genes, p53 | 1 | 2021 | 1140 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 1710 | 0.130 |
Why?
|
| Dependovirus | 1 | 2017 | 142 | 0.130 |
Why?
|
| Pyrazoles | 2 | 2015 | 1546 | 0.130 |
Why?
|
| Mice, Nude | 5 | 2021 | 4329 | 0.130 |
Why?
|
| Pyridines | 2 | 2018 | 1313 | 0.120 |
Why?
|
| Glucose | 1 | 2021 | 1218 | 0.120 |
Why?
|
| Blotting, Western | 4 | 2016 | 3584 | 0.120 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2015 | 230 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2015 | 95 | 0.120 |
Why?
|
| Cyclin D1 | 1 | 2017 | 589 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 506 | 0.120 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 1005 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2008 | 3339 | 0.120 |
Why?
|
| Phenylurea Compounds | 1 | 2018 | 600 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1402 | 0.120 |
Why?
|
| Antirheumatic Agents | 2 | 2016 | 230 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2017 | 909 | 0.110 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2013 | 86 | 0.110 |
Why?
|
| Genes, Lethal | 1 | 2013 | 131 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 4 | 2011 | 2454 | 0.110 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2013 | 118 | 0.110 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2013 | 163 | 0.100 |
Why?
|
| Humans | 24 | 2021 | 270740 | 0.100 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 5149 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2170 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2009 | 4130 | 0.100 |
Why?
|
| Pyrimidines | 2 | 2014 | 3669 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1189 | 0.090 |
Why?
|
| Glutathione | 1 | 2013 | 374 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 3597 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 1121 | 0.090 |
Why?
|
| Sirolimus | 1 | 2015 | 831 | 0.090 |
Why?
|
| Heterografts | 3 | 2018 | 738 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 768 | 0.090 |
Why?
|
| Forkhead Box Protein M1 | 2 | 2008 | 115 | 0.090 |
Why?
|
| Binding Sites | 4 | 2020 | 2255 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2014 | 5408 | 0.090 |
Why?
|
| Tumor Microenvironment | 2 | 2018 | 3035 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2015 | 2090 | 0.080 |
Why?
|
| Matrix Attachment Regions | 1 | 2009 | 2 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2016 | 5759 | 0.080 |
Why?
|
| Benzamides | 1 | 2015 | 1879 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1199 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 5315 | 0.080 |
Why?
|
| Thiazoles | 1 | 2013 | 723 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2014 | 5056 | 0.080 |
Why?
|
| NIH 3T3 Cells | 2 | 2009 | 255 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2010 | 437 | 0.070 |
Why?
|
| Crystallography, X-Ray | 2 | 2020 | 634 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2017 | 2765 | 0.070 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2006 | 115 | 0.070 |
Why?
|
| Piperazines | 1 | 2015 | 2145 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2018 | 402 | 0.060 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2004 | 43 | 0.060 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2004 | 161 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2013 | 6390 | 0.050 |
Why?
|
| Flavonoids | 1 | 2004 | 199 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 7914 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 294 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 344 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2019 | 1356 | 0.050 |
Why?
|
| Deoxycytidine | 2 | 2019 | 1389 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 1586 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 669 | 0.050 |
Why?
|
| Gamma Rays | 1 | 2001 | 237 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 540 | 0.040 |
Why?
|
| Quinazolines | 2 | 2014 | 956 | 0.040 |
Why?
|
| Mucin-1 | 1 | 2019 | 158 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2007 | 4048 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2007 | 2098 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2018 | 4942 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 979 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 7100 | 0.040 |
Why?
|
| Imidazoles | 1 | 2004 | 1065 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 14012 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 353 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 316 | 0.040 |
Why?
|
| Mutation | 2 | 2014 | 15912 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 163 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2018 | 310 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 680 | 0.030 |
Why?
|
| Protein Binding | 2 | 2018 | 3485 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2008 | 507 | 0.030 |
Why?
|
| Female | 8 | 2021 | 148940 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 396 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 7381 | 0.030 |
Why?
|
| Plasmids | 2 | 2009 | 936 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2006 | 4116 | 0.030 |
Why?
|
| Drug Design | 1 | 2018 | 372 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2016 | 3045 | 0.030 |
Why?
|
| Threonine | 1 | 2014 | 163 | 0.030 |
Why?
|
| Methionine | 1 | 2014 | 170 | 0.030 |
Why?
|
| Benzodioxoles | 1 | 2013 | 29 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2015 | 33737 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 503 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 284 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 530 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2010 | 2137 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 16689 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 4958 | 0.020 |
Why?
|
| Transfection | 2 | 2007 | 3117 | 0.020 |
Why?
|
| Adenine | 1 | 2014 | 674 | 0.020 |
Why?
|
| Base Sequence | 2 | 2008 | 5437 | 0.020 |
Why?
|
| Models, Biological | 1 | 2019 | 3194 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 703 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 2518 | 0.020 |
Why?
|
| Time Factors | 1 | 2004 | 13006 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 1810 | 0.020 |
Why?
|
| Dasatinib | 1 | 2013 | 881 | 0.020 |
Why?
|
| Blotting, Southwestern | 1 | 2009 | 3 | 0.020 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2009 | 15 | 0.020 |
Why?
|
| Piperidines | 1 | 2014 | 1100 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 5002 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 631 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2001 | 5438 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 648 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2006 | 64 | 0.020 |
Why?
|
| U937 Cells | 1 | 2006 | 178 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 1697 | 0.020 |
Why?
|
| K562 Cells | 1 | 2007 | 344 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 1496 | 0.020 |
Why?
|
| Electroporation | 1 | 2006 | 127 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 3640 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6256 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 1388 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 1580 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 840 | 0.010 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2001 | 66 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 2471 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2001 | 223 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 726 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2010 | 9292 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2001 | 1497 | 0.010 |
Why?
|
| Neoplasms | 1 | 2001 | 15927 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 7655 | 0.010 |
Why?
|